Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1999-07-27
2000-12-12
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
A61K 31235
Patent
active
061600156
ABSTRACT:
The present invention relates to compositions useful in the treatment of benign proliferative disorder neurofibromatosis comprising a farnesyl protein transferase inhibitor. Further contained in this invention are methods of treating benign proliferative disorder neurofibromatosis in a mammal, which methods comprise administering to said mammal, a farnesyl protein transferase inhibitor.
REFERENCES:
patent: 5420334 (1995-05-01), Singh et al.
patent: 5504212 (1996-04-01), deSolms et al.
patent: 5523430 (1996-06-01), Patel et al.
patent: 5532359 (1996-07-01), Marsters, Jr. et al.
patent: 5571792 (1996-11-01), Bolton et al.
Molecular and Cellular Biology, vol. 17. No. 2, pp. 862-872 (1997), by H. A. Kim, et al.
J. Neuroscience 22, vol. 2 pp. 1499, by H.A. Kim, et al.
Cancer Research, vol. 55, pp. 3569-3575 (1995), by N. Yan, et al.
Medline Abstract 91187510, vol. 16, No. 6, pp. 575-580 (1990), by Nativie, et al.
Oncogene, vol. 11, No. 2, pp. 325-335 (1995), by Kim, et al.
P. Natl. Acad. Sci. USA, vol. 91, pp. 9141-9145 (1994), by N. Khol, et al.
J. Neuroscience 22(2) 1499 Kim et al, "NF1-deficient mouse Schwann cells are anglogenic, invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase". (no publication date available).
Cancer Research 55, 3569-3575, 1995, Yan et al, "Farnesyltransferase Inhibitors Block the Neurofibromatosis Type I (NF1) Malignant Phenotype".
Medline 1990 16 (6) 575-580 Nativio et al, "Pediatric Nursing".
Oncogene vol. 11, No. 2 325-335 1995 Kim et al, "Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes".
Proc. Natl. Acad. Sci. USA vol. 91 9141-9145 1994 Kohl et al, "Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice".
Molecular and Cellular Biology, 1997 862-872 Kim et al, "Nf1-Deficient Mouse Schwann Cellas are Angiogenic and Invasive and Can be Induced to Hyperproliferate: Reversion of Some Phenotypes by an Inhibitor of Farnesyl Protein Transferase".
Daniel Mark R.
Henley III Raymond
Muthard David A.
University of Cincinnati
LandOfFree
Compounds useful in the treatment of neurofibromatosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds useful in the treatment of neurofibromatosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds useful in the treatment of neurofibromatosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-218297